Aberrant DNA methylation in multiple myeloma: A major obstacle or an opportunity?

Drug resistance (DR) of cancer cells leading to relapse is a huge problem nowadays to achieve long-lasting cures for cancer patients. This also holds true for the incurable hematological malignancy multiple myeloma (MM), which is characterized by the accumulation of malignant plasma cells in the bon...

Descripción completa

Detalles Bibliográficos
Autores principales: Muylaert, Catharina, Van Hemelrijck, Lien Ann, Maes, Anke, De Veirman, Kim, Menu, Eline, Vanderkerken, Karin, De Bruyne, Elke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9434119/
https://www.ncbi.nlm.nih.gov/pubmed/36059621
http://dx.doi.org/10.3389/fonc.2022.979569

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9434119/
https://www.ncbi.nlm.nih.gov/pubmed/36059621
http://dx.doi.org/10.3389/fonc.2022.979569

Ejemplares similares